Understanding the spectrum of cardiovascular risk in women - A primer for prevention

被引:0
作者
Satish, Priyanka [1 ]
Avenatti, Eleonora [1 ]
Patel, Jaideep [2 ]
Agarwala, Anandita [3 ]
机构
[1] Univ Texas Austin, Ctr Cardiovasc Prevent, Dell Med Sch, Ascens Texas Cardiovasc, Austin, TX USA
[2] Johns Hopkins Univ Hosp, Johns Hopkins Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
[3] Baylor Scott & White Hlth Heart Hosp Baylor Plano, Ctr Cardiovasc Dis Prevent, Plano, TX USA
关键词
Gender; Women; Cardiovascular disease; Prevention; ISCHEMIC-HEART-DISEASE; GESTATIONAL DIABETES-MELLITUS; ADVERSE PREGNANCY OUTCOMES; CONSENSUS DECISION PATHWAY; 2013; AMERICAN-COLLEGE; SEX-DIFFERENCES; SCIENTIFIC STATEMENT; CORONARY-HEART; UNITED-STATES; GENDER-DIFFERENCES;
D O I
10.1016/j.pcad.2024.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) is the leading cause of death in women worldwide and the lifetime risk of CVD in women is similar to men. However, the pathophysiology of CVD varies between women and men necessitating a sex-specific understanding of cardiovascular (CV) risk. A belief that women have a lower CVD risk than men, and an underrepresentation in clinical research for many years has led to a paucity of evidence in the prevention and management of CVD in women. Many recent efforts have tried to bridge the gap. As a result, we now know that traditional risk factors impact CVD risk differently in women when compared with men. There are also numerous sex-specific and pregnancy related risk factors that modify the risk and can predict the future development of CVD in women. This is important as risk calculators, in general, tend to misclassify risk in young women with nontraditional CVD risk factors. To address this, guidelines have introduced the concept of risk enhancers that can suggest a higher risk. The use of coronary artery calcium score can further accurately delineate risk in these women, leading to an appropriate matching of therapy to underlying risk. This review discusses implementation strategies that are essential to mitigate disparities in CVD outcomes and optimizing CVD risk in women.
引用
收藏
页码:34 / 42
页数:9
相关论文
共 130 条
  • [1] Adults (US) NOEIEP on the I Evaluation and Treatment of Obesity, 1998, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults
  • [2] The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk
    Agarwala, Anandita
    Michos, Erin D.
    Samad, Zainab
    Ballantyne, Christie M.
    Virani, Salim S.
    [J]. CIRCULATION, 2020, 141 (07) : 592 - 599
  • [3] Combined effect of low-risk dietary and lifestyle behaviors in primary prevention of myocardial infarction in women
    Akesson, Agneta
    Weismayer, Christoph
    Newby, P. K.
    Wolk, Alicja
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (19) : 2122 - 2127
  • [4] Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts
    Akintoye, Emmanuel
    Afonso, Luis
    Bengaluru Jayanna, Manju
    Bao, Wei
    Briasoulis, Alexandros
    Robinson, Jennifer
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (12):
  • [5] Prevalence and factors affecting underweight, overweight and obesity using Asian and World Health Organization cutoffs among adults in Nepal: Analysis of the Demographic and Health Survey 2016
    Al Kibria, Gulam Muhammed
    [J]. OBESITY RESEARCH & CLINICAL PRACTICE, 2019, 13 (02) : 129 - 136
  • [6] Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis
    Anagnostis, Panagiotis
    Christou, Konstantinos
    Artzouchaltzi, Aikaterini-Maria
    Gkekas, Nifon K.
    Kosmidou, Nikoletta
    Siolos, Pavlos
    Paschou, Stavroula A.
    Potoupnis, Michael
    Kenanidis, Eustathios
    Tsiridis, Eleftherios
    Lambrinoudaki, Irene
    Stevenson, John C.
    Goulis, Dimitrios G.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2019, 180 (01) : 41 - 50
  • [7] [Anonymous], 2018, NHIS - Summary Health Statistics - Adults
  • [8] [Anonymous], 2021, Low-dose aspirin use for the prevention of preeclampsia and related morbidity and mortality
  • [9] [Anonymous], 2022, PREVALENCE BOTH DIAG
  • [10] [Anonymous], 2022, Clinical Guidance for the Integration of the Findings of the Chronic Hypertension and Pregnancy (CHAP) Study